Regeneron Pharmaceuticals Company Profile
✉ Email this page to a colleague
Biologic Drugs for Regeneron Pharmaceuticals
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | 10,004,788 | 2037-12-21 | Patent claims search |
| Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | 10,047,096 | 2035-11-23 | Patent claims search |
| Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | 10,077,280 | 2036-11-15 | Patent claims search |
| Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | 10,086,010 | 2035-03-17 | Patent claims search |
| Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | 10,093,689 | 2038-05-25 | Patent claims search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.
